Artificial intelligence (AI) is rapidly reshaping many areas of healthcare — and dermatology is no exception. From smartphone skin scanners to sophisticated lesion-mapping platforms used in specialist clinics, AI is increasingly part of the diagnostic conversation.
But is AI genuinely improving dermatology diagnosis, or is it creating new risks and confusion?
For patients researching skin concerns — whether it’s a changing mole, acne, pigmentation, or a persistent rash — AI may seem like a convenient shortcut. However, dermatology is complex, visual, and highly contextual. Technology can assist, but it cannot replace clinical expertise.
In this article, we explore the role of AI in dermatology, its potential benefits and limitations, and how it fits within evidence-based, clinical care in Australia.
What Is AI in Dermatology?
Artificial intelligence in dermatology refers to computer systems trained on large datasets of skin images to recognise patterns. These systems use machine learning algorithms to:
- Analyse dermoscopic images
- Classify skin lesions
- Identify visual similarities to known diagnoses
- Assist clinicians with risk stratification
AI tools are most commonly discussed in relation to skin cancer detection, but research is expanding into acne, inflammatory conditions, and pigment disorders.
For example, some systems are trained to differentiate between benign lesions and suspicious lesions using image recognition. However, AI tools do not make medical diagnoses independently — they provide decision support that must be interpreted by a qualified medical practitioner. This is especially true when dealing and diagnosing skin cancer .
The Potential Benefits of AI in Dermatology
1. Earlier Identification of Concerning Lesions
Some AI systems have demonstrated the ability to analyse images and flag lesions that warrant further assessment. In theory, this may:
- Encourage earlier medical review
- Support triage in rural or remote areas
- Improve workflow efficiency in high-volume settings
This may be particularly relevant in Australia, where skin cancer rates are among the highest in the world.
2. Supporting (Not Replacing) Clinical Judgement
In specialist clinics, AI may assist dermatologists by:
- Comparing lesions against extensive image databases
- Providing probability-based classifications
- Supporting digital mole mapping systems
- However, AI does not assess:
- Patient history
- Symptom progression
- Immune status
- Medication influences
- Full body skin examination findings
A dermatologist integrates all of these factors during a consultation — something an algorithm cannot replicate.
Clinics such as Enrich Clinic and Dermatology Institute of Victoria (DIV) prioritise comprehensive, doctor-led assessment alongside appropriate technology where indicated.
3. Improved Access in Underserved Areas
AI-assisted teledermatology platforms may improve access for patients in regional Australia. However, telehealth and image-based assessments still require medical oversight.
The Limitations and Risks of AI in Dermatology
While promising, AI in dermatology is not without concerns.
1. Image Quality and Context Limitations
AI systems are highly dependent on image quality. Variations in:
- Lighting
- Camera resolution
- Skin tone representation in datasets
- Lesion positioning
can significantly impact accuracy. Additionally, many publicly available apps are not regulated as medical devices in Australia. The Therapeutic Goods Administration(TGA) regulates medical devices and digital health tools. Not all AI skin apps meet TGA standards.
2. Risk of False Reassurance
A low-risk output from an app does not replace a clinical diagnosis. Delayed medical review based on AI reassurance may result in:
- Late presentation of skin cancers
- Missed inflammatory or autoimmune conditions
- Progression of treatable disorder
3. Dataset Bias
AI models are only as good as the datasets used to train them. Historically, dermatology image datasets have over-represented lighter skin tones. This raises concerns about:
- Reduced accuracy in diverse populations
- Health equity implications
- Diagnostic bias
The World Health Organization has highlighted the importance of inclusive AI ethics in healthcare.
AI and Skin Cancer Detection: What Does the Evidence Say?
Research has shown that certain AI systems can perform at levels comparable to trained dermatologists in controlled study environments. However:
- Real-world conditions vary
- Studies are often retrospective
- Clinical judgement includes more than image analysis
AI may assist in identifying suspicious features, but biopsy decisions, management planning, and patient counselling remain clinical responsibilities.
At clinics such as the Dermatology Institute of Victoria, dermoscopy and specialist review are integrated into skin cancer assessment protocols — with technology supporting, not replacing, medical expertise.
AI in Cosmetic Dermatology and Skin Analysis
AI is also increasingly used in aesthetic skin analysis platforms that:
- Map pigmentation
- Assess redness
- Evaluate skin texture
- Track changes over time
While these tools may support treatment planning discussions, they do not replace clinical examination.
For patients exploring skincare ingredients, barrier repair, and evidence-based formulations, educational resources and product transparency are essential. Script Skincare provides ingredient-focused information aligned with dermatological principles.
The Human Element: Why Clinical Context Still Matters
Dermatology diagnosis involves more than pattern recognition. A dermatologist considers:
- Family history
- Occupational exposure
- Immune status
- Systemic disease
- Medication interactions
- Morphology and distribution patterns
- Symptom evolution
AI cannot palpate a lesion, assess texture, or interpret subtle contextual cues such as asymmetry across the entire body. Let not forget it takes years of training and experience to become a dermatologist .
At Enrich Clinic and DIV, consultations are doctor-led and patient-centred, ensuring that technology is integrated appropriately within a broader clinical framework.
Is AI Helping or Hindering?
The answer is nuanced.
AI May Help When:
- Used as a clinical decision-support tool
- Integrated within regulated healthcare systems
- Interpreted by qualified practitioners
- Applied to appropriate image datasets
AI May Hinder When:
- Used as a standalone diagnostic substitute
- Relied upon without medical review
- Promoted with misleading marketing claims
- Applied outside regulatory frameworks
The Future of AI in Dermatology
AI is likely to continue evolving in areas such as:
- Automated mole mapping
- Predictive risk modelling
- Treatment outcome tracking
- Clinical workflow optimisation
However, ethical governance, transparency, and regulatory compliance will remain central to safe implementation.
The goal is not replacement — but collaboration.
Technology may assist dermatologists in analysing patterns at scale, but human expertise remains essential in translating data into diagnosis and management. Everyone is indiviual and this is the level of care that is important in any healthcare situation.
Hero or Villain?
AI is neither hero nor villain in dermatology diagnosis. Most importantly, it is a tool — one that must be applied carefully, ethically, and within regulated medical practice.
For patients, the safest approach remains:
- Seek a qualified medical assessment for new or changing skin concerns
- Use AI tools cautiously
- Avoid relying solely on app-based reassurance
If you have concerns about your skin, a comprehensive consultation with a qualified dermatologist is the most reliable way to assess your condition.
While technology continues to evolve, nothing replaces an experienced clinical eye.
If you’d like your skin professionally assessed — whether for a mole check, skin cancer review or general dermatology concern — we invite you to book a consultation with our doctor-led team at ENRICH Clinic and The Dermatology Institute of Victoria
